Dec 12, 2022 9:15am EST ClearPoint Neuro Announces First Patient Enrolled in Glioblastoma Trial Using ClearPoint Prism™ Neuro Laser Therapy System at Skåne University Hospital in Sweden
Sep 23, 2022 2:45am EDT ClearPoint Neuro Announces FDA Clearance for ClearPoint Prism™ Neuro Laser Therapy System
Sep 20, 2022 4:05pm EDT ClearPoint Neuro Announces Appointment of Mazin Sabra as Chief Operating Officer
Aug 08, 2022 4:05pm EDT ClearPoint Neuro, Inc. Announces Appointment of Mary McNamara-Cullinane as Vice President of Regulatory Affairs